Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli
- 1 November 1995
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (11) , 2478-2483
- https://doi.org/10.1128/aac.39.11.2478
Abstract
Among Escherichia coli organisms isolated at St. Thomas's Hospital during the years 1990 to 1994, the frequency of resistance to amoxicillin-clavulanic acid (tested by disk diffusion in a ratio of 2:1) remained constant at about 5% of patient isolates (10 to 15% of the 41 to 45% that were amoxicillin resistant). Mechanisms of increased resistance were determined for 72 consecutively collected such amoxicillin-clavulanic acid-resistant isolates. MICs of the combination were 16-8 micrograms/ml for 51 (71%) of these and > or = 32-16 micrograms/ml for the remainder. The predominant mechanism was hyperproduction of enzymes isoelectrically cofocusing with TEM-1 (beta-lactamase activities, > 200 nmol of nitrocefin hydrolyzed per min per mg of protein) which was found in 44 isolates (61%); two isolates produced smaller amounts (approximately 150 nmol/min/mg) of such enzymes, and two isolates hyperproduced enzymes cofocusing with TEM-2. Eleven isolates produced enzymes cofocusing with OXA-1 beta-lactamase, which has previously been associated with resistance to amoxicillin-clavulanic acid. Ten isolates produced increased amounts of chromosomal beta-lactamase, and four of these additionally produced TEM-1 or TEM-2. Three isolates produced inhibitor-resistant TEM-group enzymes. In one of the enzymes (pI, 5.4), the amino acid sequence change was Met-67-->Val, and thus the enzyme is identical to TEM-34. Another (pI, 5.4) had the substitution Met-67-->Ile and is identical to IRT-I67, which we propose now be given the designation TEM-40. The third (pI, 5.2) had the substitution Arg-241-->Thr; this enzyme has not been reported previously and should be called TEM-41. The rarity and diversity of inhibitor-resistant TEM-group enzymes suggest that they are the result of spontaneous mutations that have not yet spread.Keywords
This publication has 33 references indexed in Scilit:
- Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to β-lactamase inhibitorsFEMS Microbiology Letters, 1994
- In-vitro antimicrobial susceptibility and β-lactamases of ampicillin-resistant Escherichia coliin Hong KongJournal of Antimicrobial Chemotherapy, 1994
- The north american component (the united states and canada) of an international comparative MIC trial monitoring ofloxacin resistanceDiagnostic Microbiology and Infectious Disease, 1993
- Selection of variants of the TEM-1 β lactamase, encoded by a plasmid of clinical origin, with increased resistance to β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1993
- β-Lactamases and susceptibility to β-lactam antibiotics in Escherickia coilJournal of Antimicrobial Chemotherapy, 1992
- Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1992
- TRC-1: Emergence of a clavulanic acid-resistant TEM β-lactamase in a clinical strainFEMS Microbiology Letters, 1992
- Activity of clavulanate combinations against TEM-1 β-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989Journal of Antimicrobial Chemotherapy, 1991
- Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- AMOXYCILLIN/CLAVULANATE RESISTANT ESCHERICHIA COLIThe Lancet, 1988